Amidst the macroeconomic, structural, and microeconomic shifts caused by the COVID-19 pandemic, the Indian pharmaceutical industry responded with agility, exceeding the expectations of governments and markets across geographies. The overall growth of the Indian pharmaceutical industry can be largely attributed to the industry’s leadership in supplying generic formulations to the market, supplying over 40% of